Know Cancer

or
forgot password

Clinical and Immunological Benefits of the Infusion of Pure Fish Oil Lipid Emulsion in Surgical Patients With Gastrointestinal Cancer.


Phase 2
18 Years
75 Years
Not Enrolling
Both
Surgery

Thank you

Trial Information

Clinical and Immunological Benefits of the Infusion of Pure Fish Oil Lipid Emulsion in Surgical Patients With Gastrointestinal Cancer.


Inclusion Criteria:



Elective surgical patients with confirmed (biopsy) gastrointestinal (colon or stomach)
cancer; 30-75 years old; venous assess to blood collections (40 mL) to receive parenteral
infusions of lipid emulsion; Karnofsky performance statuses of ≥60

Exclusion Criteria:

Intolerance or allergy to any ingredient in lipid emulsion; diagnosis of infectious,
inflammatory, immunologic or metabolic diseases; dementia;medicine intake that could
significantly modulate metabolism; implanted electromagnetic instruments.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Principal Investigator

Dan L. Waitzberg, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Sao Paulo, Faculty of Medicine

Authority:

Brazil: Ethics Committee

Study ID:

CAPPesq 310/04

NCT ID:

NCT01218841

Start Date:

November 2005

Completion Date:

November 2008

Related Keywords:

  • Surgery
  • Fish oil
  • Omega-3 fatty acids
  • Parenteral lipid emulsions
  • Immune response
  • Surgery
  • Gastrointestinal Neoplasms

Name

Location